Clinical Trials Directory

Trials / Completed

CompletedNCT03458468

Tranexamic Acid for the Latarjet Procedure.

A Randomised, Prospective Evaluation on the Effectiveness of Tranexamic Acid in Reducing Postoperative Swelling and Haematoma Formation After the Latarjet Procedure.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Sports Surgery Clinic, Santry, Dublin · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure. The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic Acid1g Tranexamic acid prior to skin incision
DRUGSalineEquivalent volume of saline prior to skin incision

Timeline

Start date
2018-03-01
Primary completion
2019-03-01
Completion
2019-03-01
First posted
2018-03-08
Last updated
2019-07-30

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT03458468. Inclusion in this directory is not an endorsement.

Tranexamic Acid for the Latarjet Procedure. (NCT03458468) · Clinical Trials Directory